390 related articles for article (PubMed ID: 10208190)
1. Safety of long-term treatment with HFA albuterol.
Ramsdell JW; Klinger NM; Ekholm BP; Colice GL
Chest; 1999 Apr; 115(4):945-51. PubMed ID: 10208190
[TBL] [Abstract][Full Text] [Related]
2. Comparable bronchodilation with hydrofluoroalkane-134a (HFA) albuterol and chlorofluorocarbons-11/12 (CFC) albuterol in children with asthma.
Shapiro GS; Klinger NM; Ekholm BP; Colice GL
J Asthma; 2000 Dec; 37(8):667-75. PubMed ID: 11192231
[TBL] [Abstract][Full Text] [Related]
3. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.
Bronsky E; Ekholm BP; Klinger NM; Colice GL
J Asthma; 1999; 36(1):107-14. PubMed ID: 10077140
[TBL] [Abstract][Full Text] [Related]
4. Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma.
Lumry W; Noveck R; Weinstein S; Barnhart F; Vandermeer A; Murray A; Reisner C
Ann Allergy Asthma Immunol; 2001 Mar; 86(3):297-303. PubMed ID: 11289328
[TBL] [Abstract][Full Text] [Related]
5. Proventil HFA provides bronchodilation comparable to ventolin over 12 weeks of regular use in asthmatics.
Bleecker ER; Tinkelman DG; Ramsdell J; Ekholm BP; Klinger NM; Colice GL; Slade HB
Chest; 1998 Feb; 113(2):283-9. PubMed ID: 9498940
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
Langley SJ; Sykes AP; Batty EP; Masterson CM; Woodcock A
Ann Allergy Asthma Immunol; 2002 May; 88(5):488-93. PubMed ID: 12027070
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
8. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.
Ramsdell JW; Colice GL; Ekholm BP; Klinger NM
Ann Allergy Asthma Immunol; 1998 Dec; 81(6):593-9. PubMed ID: 9892032
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.
Bhattacharya A; Bhargava S; Singh V; Talwar D; Whig J; Rebello J; Purandare S; Gogtay J
Int J Chron Obstruct Pulmon Dis; 2016; 11():1469-76. PubMed ID: 27418820
[TBL] [Abstract][Full Text] [Related]
10. Proventil HFA and ventolin have similar safety profiles during regular use.
Tinkelman DG; Bleecker ER; Ramsdell J; Ekholm BP; Klinger NM; Colice GL; Slade HB
Chest; 1998 Feb; 113(2):290-6. PubMed ID: 9498941
[TBL] [Abstract][Full Text] [Related]
11. Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications.
Boccuzzi SJ; Wogen J; Roehm JB
Clin Ther; 2000 Feb; 22(2):237-47. PubMed ID: 10743983
[TBL] [Abstract][Full Text] [Related]
12. Equivalence of salbutamol 200 microg four times daily propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. Eastern European study group.
Salat D; Popov D; Sykes AP
Respir Med; 2000 Jun; 94 Suppl B():S22-8. PubMed ID: 10919682
[TBL] [Abstract][Full Text] [Related]
13. Clinical comparability of ventolin formulated with hydrofluoroalkane or conventional chlorofluorocarbon propellants in children with asthma.
Shapiro G; Bronsky E; Murray A; Barnhart F; VanderMeer A; Reisner C
Arch Pediatr Adolesc Med; 2000 Dec; 154(12):1219-25. PubMed ID: 11115306
[TBL] [Abstract][Full Text] [Related]
14. Efficacy response of inhaled HFA-albuterol delivered via the breath-actuated Autohaler inhalation device is comparable to dose in patients with asthma.
Gross G; Cohen RM; Guy H
J Asthma; 2003; 40(5):487-95. PubMed ID: 14529098
[TBL] [Abstract][Full Text] [Related]
15. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
[TBL] [Abstract][Full Text] [Related]
16. Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group.
Jacobson K; Chervinsky P; Noonan M; Kane RE; Banerji D; Uryniak T
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):327-33. PubMed ID: 10541425
[TBL] [Abstract][Full Text] [Related]
17. Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction.
Hawksworth RJ; Sykes AP; Faris M; Mant T; Lee TH
Ann Allergy Asthma Immunol; 2002 May; 88(5):473-7. PubMed ID: 12027068
[TBL] [Abstract][Full Text] [Related]
18. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler.
Donnell D; Harrison LI; Ward S; Klinger NM; Ekholm BP; Cooper KM; Porietis I; McEwen J
Eur J Clin Pharmacol; 1995; 48(6):473-7. PubMed ID: 8582466
[TBL] [Abstract][Full Text] [Related]
19. Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.
Chopra N; Williams M; Rimmer M; Kahl L; Jenkins M;
Respir Med; 2005 Apr; 99 Suppl A():S1-S10. PubMed ID: 15777603
[TBL] [Abstract][Full Text] [Related]
20. Equivalence of as-required salbutamol propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. German Study Group.
Baumgarten CR; Dorow P; Weber HH; Gebhardt R; Kettner J; Sykes AP
Respir Med; 2000 Jun; 94 Suppl B():S17-21. PubMed ID: 10919681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]